AARD Aardvark Therapeutics, Inc. Common Stock
Healthcare$4.54+0.67%ClosedMarket Cap: $99.0M
As of 2026-05-25
Analyst Consensus
Consensus
Hold
Target (Consensus)
$22.75
Target (Median)
$20.50
Target Range
$3.00 - $47.00
Upside from current price: 401.1%
Rating Distribution
0 Strong Buy8 Buy4 Hold1 Sell1 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-05-15 | BTIG | downgrade | Neutral | Buy |
| 2026-05-15 | Morgan Stanley | downgrade | Underweight | Equal Weight |
| 2026-05-15 | B. Riley Securities | maintain | Buy | Buy |
| 2026-03-24 | BTIG | maintain | Buy | Buy |
| 2026-03-02 | Morgan Stanley | downgrade | Equal Weight | Overweight |
| 2026-03-02 | RBC Capital | downgrade | Sector Perform | Outperform |
| 2026-03-02 | Stifel | downgrade | Hold | Buy |
| 2026-03-02 | HC Wainwright & Co. | downgrade | Neutral | Buy |
| 2026-03-02 | Oppenheimer | maintain | Outperform | Outperform |
| 2026-02-10 | BTIG | maintain | Buy | Buy |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Thu Dec 31 | $-3.79 | $300.0K | 9 |
| Fri Dec 31 | $-3.26 | $1.0M | 8 |
| Sun Dec 31 | $-2.93 | $6.6M | 6 |
| Mon Dec 31 | $-1.64 | $89.0M | 4 |